Award
NIH Reporter #RFA-CA-19-007
The Ohio State University as a Lead Academic Organization (LAO) for the Experimental Therapeutics Clinical Trials Network
Recipient
The Ohio State University
Awarded
April 21, 2025
Identifier
RFA-CA-19-007
Award to The Ohio State University as Lead Academic Organization for clinical trials network focusing on cancer therapies, funded by the National Cancer Institute.
Description
This project involves clinical research on cancer therapies, including the development and testing of new agents, with a focus on translational research, immunotherapy, and targeted treatments. The project is funded by the National Cancer Institute and involves collaboration among multiple cancer centers.